AARTIDRUGS

Aarti Drugs Balance Sheet

₹416.75-2.81%
Market cap
₹3,804 crore
P/E
19.9
P/B
2.46
ROE
13.4%
Dividend yield
1.20%

As of Mar 2022, Aarti Drugs had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings rose 97.07% from Mar 2023.

Aarti Drugs balance sheet

As at each financial year end, newest first. H1 = half-year.

Aarti Drugs balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital50092.691.9491.2791.27
Reserves8,5001,0211,1551,2401,400
Borrowings1,200609564615577
Other liabilities3,500620586590689
Total liabilities13,7002,4212,4322,5752,815
Fixed assets6,5008861,0541,1501,211
Capital work in progress400100100100100
Investments2,500484486515563
Other assets4,300726730772845
Total assets13,7002,4212,4322,5752,815

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Aarti Drugs balance sheet — frequently asked questions

What is the total debt of Aarti Drugs?

Aarti Drugs reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹609 crore as of Mar 2023.

What is Aarti Drugs' debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Aarti Drugs' debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Aarti Drugs' total assets?

Aarti Drugs' total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Aarti Drugs With ATS

Track AARTIDRUGS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.